(Q80543288)
Statements
Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting (English)
Roberto Musso
Elena Santagostino
Albert Faradji
Jan van der Meer
Jørgen Ingerslev
Thierry Lambert
Monika Maas-Enriquez
Eduard Gorina
KOGENATE Bayer European PMS Study Group